Table 2 Patient characteristics. (2) Discontinuation/change group
Concomitant drug-change | Drug-change | Dose-adjustment | Discontinuation (short-term) | |
|---|---|---|---|---|
Patients (N) | 37 | 329 | 98 | 278 |
Men/women (N) | 24/13 | 150/179 | 44/54 | 103/175 |
Mean age (years) | 66.7 | 66.8 | 68.1 | 70.9 |
Mean treatment duration (weeks) | 144 ± 3.50 | 66.6 ± 3.53 | 143 ± 3.71 | 63.8 ± 4.00 |
Age (years) | Duration (weeks) | |||
Mean | S.D. | Mean | S.D. | |
Long-term continued use | 68.8 | 10.9 | 177 | 3.61 |
Discontinuation (long-term) | 73.8 | 11.8 | 158 | 3.54 |
Concomitant drug-change | 66.7 | 11.0 | 144 | 3.50 |
Drug-change | 66.8 | 11.1 | 66.6 | 3.53 |
Dose-adjustment | 68.1 | 11.2 | 143 | 3.71 |
Discontinuation (short-term) | 70.9 | 12.5 | 63.8 | 4.00 |